

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - Solvonis Therapeutics PLC on Tuesday announced the appointment of neuroscience professor David Nutt as its chief scientific officer,...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:


(Alliance News) - Solvonis Therapeutics PLC said on Wednesday that it will be focusing on funding its research projects, after reporting no sources of...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:


(Alliance News) - Solvonis Therapeutics PLC on Wednesday reported "positive progress" on its European patent application for the Awkn-Sdn-14 programme...


(Alliance News) - Solvonis Therapeutics PLC on Monday said it entered into an arrangement agreement to buy Toronto-based Awakn Life Sciences Corp.